Norah C. Feeny
Case Western Reserve University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Norah C. Feeny.
Journal of Consulting and Clinical Psychology | 2005
Edna B. Foa; Elizabeth A. Hembree; Shawn P. Cahill; Sheila A. M. Rauch; David S. Riggs; Norah C. Feeny; Elna Yadin
Female assault survivors (N=171) with chronic posttraumatic stress disorder (PTSD) were randomly assigned to prolonged exposure (PE) alone, PE plus cognitive restructuring (PE/CR), or wait-list (WL). Treatment, which consisted of 9-12 sessions, was conducted at an academic treatment center or at a community clinic for rape survivors. Evaluations were conducted before and after therapy and at 3-, 6-, and 12-month follow-ups. Both treatments reduced PTSD and depression in intent-to-treat and completer samples compared with the WL condition; social functioning improved in the completer sample. The addition of CR did not enhance treatment outcome. No site differences were found: Treatment in the hands of counselors with minimal cognitive- behavioral therapy (CBT) experience was as efficacious as that of CBT experts. Treatment gains were maintained at follow-up, although a minority of patients received additional treatment.
Journal of Clinical Child Psychology | 2001
Edna B. Foa; Kelly M. Johnson; Norah C. Feeny; Kimberli R. H. Treadwell
Reports on the development and preliminary validation of the Child PTSD Symptom Scale (CPSS) for children and adolescents. The CPSS is a new instrument that was developed to assess the severity of Diagnostic and Statistical Manual of Mental Disorders (4th ed.; American Psychiatric Association, 1994) posttraumatic stress disorder symptoms in children exposed to trauma. The CPSS was administered to 75 school-age children approximately 2 years after the 1994 Northridge, California, earthquake. The psychometric properties of the CPSS show high internal consistency and test-retest reliability for both the total score and the three subscales. Convergent validity with the Child Post-Traumatic Stress Disorder Reaction Index (CPTSD-RI) was established. As expected, the correlations of the CPSS with depression and anxiety measures were lower than those with the CPTSD-RI, providing some support for discriminant validity of the CPSS. These results suggest that the CPSS is a useful tool for the assessment of posttraumatic stress disorder (PTSD) severity and for the screening of PTSD diagnosis among traumatized children.
Journal of the American Academy of Child and Adolescent Psychiatry | 2003
John S. March; Susan G. Silva; Stephen Petrycki; John F. Curry; Karen C. Wells; John A. Fairbank; Barbara J. Burns; Marisa Elena Domino; Benedetto Vitiello; Joanne B. Severe; Charles D. Casat; Jeanette Kolker; Norah C. Feeny; Robert L. Findling; Sheridan Stull; Susan Baab; Bruce Waslick; Michael Sweeney; Lisa M. Kentgen; Rachel Kandel; John T. Walkup; Golda S. Ginsburg; Elizabeth Kastelik; Hyung Koo; Christopher J. Kratochvil; Diane May; Randy LaGrone; Martin Harrington; Anne Marie Albano; Glenn S. Hirsch
OBJECTIVES A rapidly growing empirical literature on the treatment of major depressive disorder (MDD) in youth supports the efficacy of short-term treatment with depression-specific cognitive-behavioral therapy or medication management with a selective serotonin reuptake inhibitor. These studies also identify a substantial probability of partial response and of relapse, which might be addressed by more intensive, longer-term treatments. METHOD Funded by the National Institute of Mental Health, the Treatment for Adolescents With Depression Study (TADS) is a multicenter, randomized, masked effectiveness trial designed to evaluate the short-term (12-week) and long-term (36-week) effectiveness of four treatments for adolescents with MDD: fluoxetine, cognitive-behavioral therapy, their combination, and, acutely, pill placebo. A volunteer sample of 432 subjects aged 12-17 years (inclusive) with a primary DSM-IV diagnosis of MDD who are broadly representative of patients seen in clinical practice will enter the study. The primary dependent measures rated blindly by an independent evaluator are the Childrens Depression Rating Scale and, for responder analysis, a dichotomized Clinical Global Impressions-Improvement score. Consistent with an intent-to-treat analysis, all patients, regardless of treatment status, return for all scheduled assessments. RESULTS This report describes the design of the trial, the rationale for the design choices made, and the methods used to carry out the trial. CONCLUSION When completed, TADS will improve our understanding of how best to initiate treatment for adolescents with MDD.
Journal of Traumatic Stress | 2013
Nina K. Rytwinski; Michael D. Scur; Norah C. Feeny; Eric A. Youngstrom
Although co-occurring posttraumatic stress disorder (PTSD) and major depressive disorder (MDD) is associated with greater distress, impairment, and health care utilization than PTSD alone, the magnitude of this problem is uncertain. This meta-analysis aimed to estimate the mean prevalence of current MDD co-occurrence among individuals with PTSD and examine potential moderating variables (U.S. nationality, gender, trauma type, military service, referral type) that may influence the rate of PTSD and MDD co-occurrence. Meta-analytic findings (k = 57 studies; N = 6,670 participants) revealed that 52%, 95% confidence interval [48, 56], of individuals with current PTSD had co-occurring MDD. When outliers were removed, military samples and interpersonal traumas demonstrated higher rates of MDD among individuals with PTSD than civilian samples and natural disasters, respectively. U.S. nationality, gender, and referral type did not significantly account for differences in co-occurrence rates. This high co-occurrence rate accentuates the importance of routinely assessing MDD among individuals with PTSD and continuing research into the association between these disorders.
Archives of General Psychiatry | 2011
John F. Curry; Susan G. Silva; Paul Rohde; Golda S. Ginsburg; Christopher J. Kratochvil; Anne D. Simons; Jerry Kirchner; Diane May; Betsy D. Kennard; Taryn L. Mayes; Norah C. Feeny; Anne Marie Albano; Sarah Lavanier; Mark A. Reinecke; Rachel H. Jacobs; Emily G. Becker-Weidman; Elizabeth B. Weller; Graham J. Emslie; John T. Walkup; Elizabeth Kastelic; Barbara J. Burns; Karen C. Wells; John S. March
CONTEXT Major depressive disorder in adolescents is common and impairing. Efficacious treatments have been developed, but little is known about longer-term outcomes, including recurrence. OBJECTIVES To determine whether adolescents who responded to short-term treatments or who received the most efficacious short-term treatment would have lower recurrence rates, and to identify predictors of recovery and recurrence. DESIGN Naturalistic follow-up study. SETTING Twelve academic sites in the United States. PARTICIPANTS One hundred ninety-six adolescents (86 males and 110 females) randomized to 1 of 4 short-term interventions (fluoxetine hydrochloride treatment, cognitive behavioral therapy, their combination, or placebo) in the Treatment for Adolescents With Depression Study were followed up for 5 years after study entry (44.6% of the original Treatment for Adolescents With Depression Study sample). MAIN OUTCOME MEASURES Recovery was defined as absence of clinically significant major depressive disorder symptoms on the Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version interview for at least 8 weeks, and recurrence was defined as a new episode of major depressive disorder following recovery. RESULTS Almost all participants (96.4%) recovered from their index episode of major depressive disorder during the follow-up period. Recovery by 2 years was significantly more likely for short-term treatment responders (96.2%) than for partial responders or nonresponders (79.1%) (P < .001) but was not associated with having received the most efficacious short-term treatment (the combination of fluoxetine and cognitive behavioral therapy). Of the 189 participants who recovered, 88 (46.6%) had a recurrence. Recurrence was not predicted by full short-term treatment response or by original treatment. However, full or partial responders were less likely to have a recurrence (42.9%) than were nonresponders (67.6%) (P = .03). Sex predicted recurrence (57.0% among females vs 32.9% among males; P = .02). CONCLUSIONS Almost all depressed adolescents recovered. However, recurrence occurs in almost half of recovered adolescents, with higher probability in females in this age range. Further research should identify and address the vulnerabilities to recurrence that are more common among young women.
Trauma, Violence, & Abuse | 2000
Edna B. Foa; Michele Cascardi; Lori A. Zoellner; Norah C. Feeny
This article presents a brief summary of the literature on variables associated with cessation or continuation of partner violence with the aim of generating two conceptual models: psychological and environmental. Toward this goal, the authors first examine existing theoretical models of womens influence on partner violence. Second, they review psychological and environmental variables associated with womens influence on partner violence. To capture the richness and complexity of factors involved in partner violence, the two models include multifaceted constructs such as psychological difficulties, resilience, and partner violence. The conceptual models are designed to provide a framework for developing research that will enhance the understanding about womens influence on the course of partner violence and, in turn, will inform interventions aimed at helping women reduce violence in their lives.
Professional Psychology: Research and Practice | 2004
Norah C. Feeny; Edna B. Foa; Kimberli R. H. Treadwell; John S. March
What treatments work for children who have posttraumatic stress disorder (PTSD)? Perhaps more important, what else do clinicians need to learn? In this article, the authors focus on treatment research in the area of trauma and PTSD in youth, in an attempt to highlight the clinical implications of such work and to identify the areas in which additional research is needed. Overall, there is emerging evidence that a variety of cognitive and behavioral programs are effective in treating youth with PTSD. In spite of such evidence, additional research is needed to shore up the scientific base for effective clinical practice with these youth. Psychologists working with traumatized youth will find this article a useful update on the state of evidence for cognitive-behavioral interventions in the treatment of PTSD.
American Journal of Psychiatry | 2009
John March; Susan G. Silva; John F. Curry; Karen C. Wells; John A. Fairbank; Barbara J. Burns; Marisa Elena Domino; Benedetto Vitiello; Joanne B. Severe; Charles D. Casat; Karyn Riedal; Marguerita Goldman; Norah C. Feeny; Robert L. Findling; Sheridan Stull; Susan Baab; Elizabeth B. Weller; Michele Robins; Ronald A. Weller; Naushad Jessani; Bruce Waslick; Michael Sweeney; Randi Dublin; John T. Walkup; Golda S. Ginsburg; Elizabeth Kastelic; Hyung Koo; Christopher J. Kratochvil; Diane May; Randy LaGrone
OBJECTIVE The Treatment for Adolescents With Depression Study (TADS) evaluates the effectiveness of fluoxetine, cognitive-behavioral therapy (CBT), and their combination in adolescents with major depressive disorder. The authors report effectiveness outcomes across a 1-year naturalistic follow-up period. METHOD The randomized, controlled trial was conducted in 13 academic and community sites in the United States. Stages I, II, and III consisted of 12, 6, and 18 weeks of acute, consolidation, and continuation treatment, respectively. Following discontinuation of TADS treatments at the end of stage III, stage IV consisted of 1 year of naturalistic follow-up. The participants were 327 subjects between the ages of 12 and 17 with a primary DSM-IV diagnosis of major depressive disorder. No TADS treatment was provided during the follow-up period; treatment was available in the community. The primary dependent measures, rated by an independent evaluator blind to treatment status, were the total score on the Childrens Depression Rating Scale-Revised and the rate of response, defined as a rating of much or very much improved on the Clinical Global Impressions improvement measure. RESULTS Sixty-six percent of the eligible subjects participated in at least one stage IV assessment. The benefits seen at the end of active treatment (week 36) persisted during follow-up on all measures of depression and suicidality. CONCLUSIONS In contrast to earlier reports on short-term treatments, in which worsening after treatment is the rule, the longer treatment in the TADS was associated with persistent benefits over 1 year of naturalistic follow-up.
Cognitive and Behavioral Practice | 2003
Norah C. Feeny; Elizabeth A. Hembree; Lori A. Zoellner
Considerable evidence exists for the efficacy and tolerability of exposure therapy for PTSD (cf. Foa & Rothbaum, 1998 ; Rothbaum, Meadows, Resick, & Foy, 2000) . However, the use of exposure therapy in real-world settings has lagged behind such findings. It is our belief that this gap between science and practice is partly due to several clinical myths regarding the use of exposure therapy. In this article, we outline four such myths, discuss relevant empirical findings, and argue that exposure therapy is indeed applicable for the treatment of a variety of patients with PTSD by clinicians in a variety of real-world settings.
Journal of Clinical Child and Adolescent Psychology | 2011
Andres De Los Reyes; Eric A. Youngstrom; Shairy C. Pabón; Jennifer Kogos Youngstrom; Norah C. Feeny; Robert L. Findling
In this study, we examined the internal consistency of informant discrepancies in reports of youth behavior and emotional problems and their unique relations with youth, caregiver, and family characteristics. In a heterogeneous multisite clinic sample of 420 youths (ages 11–17 years), high internal consistency estimates were observed across measures of informant discrepancies. Further, latent profile analyses identified systematic patterns of discrepancies, characterized by their magnitude and direction (i.e., which informant reported greater youth problems). In addition, informant discrepancies systematically and uniquely related to informants’ own perspectives of youth mood problems, and these relations remained significant after taking into account multiple informants’ reports of informant characteristics widely known to relate to informant discrepancies. These findings call into question the prevailing view of informant discrepancies as indicative of unreliability and/or bias on the part of informants’ reports of youths’ behavior.